Evidence map›Paper›PMID 27703992›Full record

ArticleOpen forum infectious diseases2016

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.

Robert L Glaubius, Urvi M Parikh, Greg Hood, Kerri J Penrose, Eran Bendavid, John W Mellors, Ume L Abbas

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. The role of rilpivirine in Southern Africa.Southern African journal of HIV medicine · 2019
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Robert L GlaubiusDepartments of Infectious Disease and Quantitative Health Sciences , Cleveland Clinic , Ohio.
Urvi M ParikhDivision of Infectious Diseases , School of Medicine, University of Pittsburgh.
Greg HoodPittsburgh Supercomputing Center , Carnegie Mellon University , Pennsylvania.
Kerri J PenroseDivision of Infectious Diseases , School of Medicine, University of Pittsburgh.
Eran BendavidDivision of Infectious Diseases, Department of Medicine , Stanford University , California.
John W MellorsDivision of Infectious Diseases , School of Medicine, University of Pittsburgh.
Ume L AbbasDepartments of Infectious Disease and Quantitative Health Sciences, Cleveland Clinic, Ohio; Section of Infectious Diseases, Department of Medicine, and Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
University of Pittsburgh · USBaylor College of Medicine · USCleveland Clinic · USPittsburgh Supercomputing Center · USStanford University · US

Funding

Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR01DA015612 · NIDA · STANFORD UNIVERSITY · PI OWENS, DOUGLAS K · 2002 to 2017
$9.4M
Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR37DA015612 · NIDA · STANFORD UNIVERSITY · PI DOUGLAS K OWENS · 2019 to 2026
$6.3M
NIDA NIH HHS R01 DA015612NIDA NIH HHS R37 DA015612
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug resistanceHIV preventionmathematical modelpre-exposure prophylaxisSouth Africa

Identifiers

PMID27703992
PMCPMC5047428
OpenAlexW2487182128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.